Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,726.13
(
0.30%
)
News Focus
News Focus
Post# of 257267
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 196812

Monday, 11/09/2015 7:24:33 PM

Monday, November 09, 2015 7:24:33 PM

Post# of 257267
RNVC’s pro forma cash at 9/30/15—including net proceeds from the Nov2009 financing—was ~$271M; guidance for cash at 12/31/15 is >$245M, implying an operating cash burn of as much as $36M in 4Q15:

http://finance.yahoo.com/news/revance-therapeutics-releases-third-quarter-210300840.html

RVNC's needs all the cash it can get insofar as the phase-3 program for RT002 (and RT001) will be quite expensive without a partner (#msg-118173728).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today